Out-of-hospital ECPR

摘要

Veno-arterial extracorporeal membrane oxygenation (ECMO) has been used successfully for several years in refractory cardiogenic shock. Of note, the survival rate is markedly affected by the underlying patient condition, and especially their capacity to recover. Combes et al. 1 demonstrated a short- and a long-term survival rate (11 months of median follow-up time) of, respectively, 42 and 36% in a large series of patients with cardiogenic shock of various origins, including fulminant myocarditis (30%), post-cardiotomy (24%), post-myocardial infarction (15%), and shock after heart transplantation (15%). In that study, 1 implantation during cardiopulmonary resuscitation (CPR) was associated with a marked increase in the risk of death (OR 20.68 (1.09–392.03)).